Inventor profile of:

Bryan D. Smith

City:

Waltham, Massachusetts

Country:

United States

Published Applications:

16

Last publication date:

2026-02-05

Top Assignees for applications by Bryan D. Smith

The entities that hold a legal rights for patent applications filed by inventor Smith Bryan D.:

Recent patent applications by Smith Bryan D.

Bryan D. Smith from Waltham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-05
US20260034131A1
Human necessities

METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS

#2 | 2025-06-26
US20250206729A1
Chemistry; metallurgy

DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOF

#3 | 2025-06-26
US20250205237A1
Human necessities

METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS

#4 | 2025-03-20
US20250090506A1
Human necessities

COMBINATION THERAPY FOR THE TREATMENT OF MASTOCYTOSIS

#5 | 2024-12-19
US20240415818A1
Human necessities

COMBINATION THERAPY FOR THE TREATMENT OF GASTROINTESTINAL STROMAL TUMORS

#6 | 2024-06-06
US20240180923A1
Human necessities

METHODS OF TREATING DISORDERS WITH ULK INHIBITORS

#7 | 2023-12-28
US20230414614A1
Human necessities

Methods of treating disorders using CSF1R inhibitors

#8 | 2023-09-07
US20230277522A9
Human necessities

METHODS FOR TREATING VASCULAR MALFORMATIONS

#9 | 2022-11-24
US20220370424A1
Human necessities

USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA

#10 | 2022-11-24
US20220370423A1
Human necessities

USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA

#11 | 2022-05-12
US20220143018A1
Human necessities

Methods of treating disorders using CSF1R inhibitors

#12 | 2022-02-17
US20220047573A1
Human necessities

METHODS FOR TREATING VASCULAR MALFORMATIONS

#13 | 2021-05-20
US20210145805A1
Human necessities

Combination therapy for the treatment of gastrointestinal stromal tumor

#14 | 2021-01-21
US20210015801A1
Human necessities

USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA

#15 | 2020-11-12
US20200352920A1
Human necessities

Combination therapy for the treatment of mastocytosis

#16 | 2020-08-13
US20200253973A1
Human necessities

Methods of treating disorders using CSF1R inhibitors

InventorID:

2818043 ⎘